Routine cell-free DNA prenatal screening identifies pregnancies at high risk for cystic fibrosis that may benefit from fetal therapy. - Wynn, J.; Rego, S.; Chandler-Brown, D.; Carter, R.; Talati, A.; Zaretsky, M.; Trimble, A. (Journal of Cystic Fibrosis, 2025)